Sapio Sciences
Private Company
Total funding raised: $15M
Overview
Sapio Sciences has established itself as a key player in the lab informatics software sector by developing an integrated, AI-native platform designed to unify and simplify data management across the entire drug lifecycle. The company's flagship products—Sapio LIMS, Sapio ELaiN (an 'AI co-scientist'), and the Sapio Scientific Data Cloud—target the critical pain points of data silos, manual processes, and compliance in life sciences R&D and manufacturing. By emphasizing radical configurability without extensive programming, Sapio aims to serve a diverse customer base from research labs to GMP manufacturing facilities, positioning itself as a modern alternative to legacy and piecemeal informatics solutions.
Technology Platform
A unified, agentic AI-powered lab informatics platform combining a no-code LIMS (Sapio LIMS), an AI co-scientist lab notebook (Sapio ELaiN), and an enterprise scientific data management cloud (Sapio Scientific Data Cloud) on a shared native AI foundation.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Sapio competes in a fragmented market with large players like LabVantage and Thermo Fisher, enterprise software giants like SAP, and specialized ELN/LIMS vendors. Its key differentiators are its unified AI-native platform, radical no-code configurability, and the positioning of its ELaiN as a proactive 'AI co-scientist' rather than a passive electronic notebook.